Suchergebnisse - "Prostatic Neoplasms therapy"

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results

Autoren: J. Rubio‐Briones A. Borque‐Fernando L. M. Esteban Escaño et al.

Quelle: Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza

Schlagwörter: Aged, 80 and over, Male, Persona de Mediana Edad, Anciano, España, Prostatic Neoplasms, Neoplasias de la Próstata, Middle Aged, Estudios Longitudinales, Sistema de Registros, Magnetic Resonance Imaging, Anciano de 80 o más Años, Humanos, Spain, Humans, Aged Aged, 80 and over Humans Longitudinal Studies Magnetic Resonance Imaging Male Middle Aged Prostatic Neoplasms* / diagnosis Prostatic Neoplasms* / epidemiology Prostatic Neoplasms* / mortality Prostatic Neoplasms* / pathology Prostatic Neoplasms* / therapy Registries Spain / epidemiology Watchful Waiting* / statistics & numerical data, Longitudinal Studies, Registries, Espera Vigilante, Watchful Waiting, Masculino, Imagen por Resonancia Magnética, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: http://zaguan.unizar.es/record/162740
https://hdl.handle.net/20.500.13003/25885

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review

Autoren: Rene Novysedlak Miray Guney Majd Al Khouri et al.

Quelle: Oncology
Oncology, vol. 103, no. 6, pp. 521-545

Schlagwörter: Humans, Prostatic Neoplasms/immunology, Prostatic Neoplasms/pathology, Prostatic Neoplasms/therapy, Tumor Microenvironment/immunology, Male, T-Lymphocytes, Regulatory/immunology, Tumor-Associated Macrophages/immunology, Immunotherapy/methods, CD4, CD8, Immunology, Immunotherapy, Metastatic, Myeloid-derived suppressor cells, Neutrophils, Prostate tumor, T cells, Tertiary lymphoid structures, Tumor-associated macrophages, Review

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39380471
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F33B7BC8896A2
https://serval.unil.ch/resource/serval:BIB_F33B7BC8896A.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F33B7BC8896A

Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival

Autoren: Siech C. de Angelis M. Di Bello F. et al.

Quelle: Ann Surg Oncol

Schlagwörter: Male, Adult, Leiomyosarcoma, Prostatectomy, Prostatic Neoplasms, Sarcoma, Middle Aged, Prognosis, Cancer-specific mortality, Mesenchymal tumor, Prostate cancer, SEER, Variant histology, Combined Modality Therapy, Survival Rate, Rhabdomyosarcoma, Humans, Original Article, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/pathology [MeSH], Sarcoma/mortality [MeSH], Leiomyosarcoma/therapy [MeSH], Male [MeSH], Sarcoma/therapy [MeSH], Combined Modality Therapy [MeSH], Follow-Up Studies [MeSH], Leiomyosarcoma/mortality [MeSH], SEER Program [MeSH], Adult [MeSH], Humans [MeSH], Leiomyosarcoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Sarcoma/pathology [MeSH], Prostatectomy/mortality [MeSH], Rhabdomyosarcoma/therapy [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Rhabdomyosarcoma/mortality [MeSH], Rhabdomyosarcoma/pathology [MeSH], SEER Program, Aged, Follow-Up Studies, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39313727
https://repository.publisso.de/resource/frl:6505635

Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P)

Autoren: Sven Löffeler Helena Bertilsson Christoph Müller et al.

Weitere Verfasser: Sven Löffeler Helena Bertilsson Christoph Müller et al.

Quelle: BJU International
Löffeler, S, Bertilsson, H, Müller, C, Aas, K, Haugnes, H S, Aksnessæther, B, Pesonen, M, Thon, K, Tandstad, T, Murtola, T, Poulsen, M H, Nordstrøm, T, Vigmostad, M N, Ottosson, F, Holmsten, K, Christiansen, O, Slaaen, M, Haug, E S, Storås, A H, Asphaug, L, Rannikko, A, Brasso, K, Scandinavian Prostatic Cancer Group (SPCG) & Norwegian Get-Randomized (GRand) Initiative 2024, ' Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P) ', BJU International, vol. 133, no. 6, pp. 680-689 . https://doi.org/10.1111/bju.16314

Schlagwörter: Male, non-metastatic prostate cancer, curative treatment, elderly patients, Conservative Treatment, Prostatic Neoplasms/therapy, 80 and over, Humans, Multicenter Studies as Topic, Clinical Trials, prostatakreft, geriatric oncology, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Prostatectomy, Prostatic Neoplasms, clinical trial, prostate cancer, 16. Peace & justice, 3. Good health, Phase III as Topic, VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762, Clinical Trials, Phase III as Topic, Quality of Life

Dateibeschreibung: application/pdf; fulltext

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38469686
https://hdl.handle.net/11250/3139363
https://curis.ku.dk/ws/files/392581821/BJU_International_2024_L_ffeler_Protocol_of_a_randomised_controlled_trial_comparing_immediate_curative_therapy_with.pdf
https://portal.findresearcher.sdu.dk/da/publications/61073421-afef-400c-a818-ad972e0ef221
https://doi.org/10.1111/bju.16314
https://hdl.handle.net/10037/33237

Inzidenz, Behandlung und Prognose des Prostatakarzinoms in Baden-Württemberg: Analyse anhand von Krebsregisterdaten

Autoren: Worst, Thomas Stefan Surovtsova, Irina Vogel, Tilo et al.

Quelle: Urologie
Die Urologie, 63(7):681-692

Schlagwörter: Aged, 80 and over [MeSH], Aged [MeSH], Prostatic Neoplasms/pathology [MeSH], Germany/epidemiology [MeSH], Originalien, Male [MeSH], Robot-assisted surgery, Therapieverfahren, Radikale Prostatektomie, Real world data, Tumor register, Roboterassistierte Chirurgie, Adult [MeSH], Humans [MeSH], Prostatic Neoplasms/epidemiology [MeSH], Incidence [MeSH], Middle Aged [MeSH], Krebsregister, Therapeutic procedures, Radical prostatectomy, Real-World-Daten, Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatectomy [MeSH], Prostatic Neoplasms/diagnosis [MeSH], Registries [MeSH]

Zugangs-URL: https://repository.publisso.de/resource/frl:6521055

European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

Autoren: Oprea-Lager DE MacLennan S Bjartell A et al.

Weitere Verfasser: Oprea-Lager DE MacLennan S Bjartell A et al.

Quelle: Oprea-Lager, D-E, MacLennan, S, Bjartell, A, Briganti, A, Burger, I A, de Jong, I, de Santis, M, Eberlein, U, Emmett, L, Fizazi, K, Gillessen, S, Herrmann, K, Heskamp, S, Iagaru, A, Jereczek-Fossa, B A, Kunikowska, J, Lam, M, Nanni, C, O'Sullivan, J M, Panebianco, V, Sala, E, Sathekge, M, Sosnowski, R, Tilki, D, Tombal, B, Treglia, G, Tunariu, N, Walz, J, Yakar, D, Dierckx, R, Sartor, O & Fanti, S 2024, 'European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer', European Urology, vol. 85, no. 1, pp. 49-60. https://doi.org/10.1016/j.eururo.2023.09.003
European Urology, 85, 1, pp. 49-60
European Urology, Vol. 85, no. 1, p. 49-60 (2024)
European urology, vol. 85, no. 1, pp. 49-60
Oprea-Lager, D-E, MacLennan, S, Bjartell, A, Briganti, A, Burger, I A, de Jong, I, De Santis, M, Eberlein, U, Emmett, L, Fizazi, K, Gillessen, S, Herrmann, K, Heskamp, S, Iagaru, A, Jereczek-Fossa, B A, Kunikowska, J, Lam, M, Nanni, C, O'Sullivan, J M, Panebianco, V, Sala, E, Sathekge, M, Sosnowski, R, Tilki, D, Tombal, B, Treglia, G, Tunariu, N, Walz, J, Yakar, D, Dierckx, R, Sartor, O & Fanti, S 2024, 'European Association of Nuclear Medicine Focus 5: consensus on molecular imaging and theranostics in prostate cancer', European Urology, vol. 85, no. 1, pp. 49-60. https://doi.org/10.1016/j.eururo.2023.09.003

Schlagwörter: 2748 Urology, Male, SDG-03: Good health and well-being, Supplementary Data, Humans, Precision Medicine, Nuclear Medicine, Prostatic Neoplasms/diagnostic imaging, Prostatic Neoplasms/therapy, Prostatic Neoplasms/pathology, Positron-Emission Tomography, Molecular Imaging, Molecular hybrid imaging, Nuclear medicine, Prostate cancer, Systemic radioligand therapy, Theranostics, Urology, Medizin, 610 Medicine & health, RC0254, SDG 3 - Good Health and Well-being, Positron emission tomography/computed tomography (PET/CT), Medical Imaging - Radboud University Medical Center, Prostatespecific membrane antigen (PSMA), name=SDG 3 - Good Health and Well-being, RC0254 Neoplasms. Tumors. Oncology (including Cancer), Prostate Cancer, Prostatic Neoplasms, 10181 Clinic for Nuclear Medicine, 3. Good health

Dateibeschreibung: application/pdf; ZORA252874.pdf - application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet; application/vnd.openxmlformats-officedocument.wordprocessingml.document

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37743194
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/301044
https://doi.org/10.1016/j.eururo.2023.09.003
https://hdl.handle.net/11370/7cbe1d03-8e8b-4c38-a368-6aef072f1b7e
https://research.rug.nl/en/publications/7cbe1d03-8e8b-4c38-a368-6aef072f1b7e
https://doi.org/10.1016/j.eururo.2023.09.003
https://research.vumc.nl/en/publications/86992e31-7b82-46f3-8f94-ff74957f218c
https://dspace.library.uu.nl/handle/1874/450571
https://repository.ubn.ru.nl/handle/2066/301044
https://repository.ubn.ru.nl//bitstream/handle/2066/301044/301044.pdf
https://hdl.handle.net/2078.1/285929
https://serval.unil.ch/notice/serval:BIB_E1C3DE87A2A3
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E1C3DE87A2A33
https://serval.unil.ch/resource/serval:BIB_E1C3DE87A2A3.P001/REF.pdf
https://hdl.handle.net/10807/302990
https://doi.org/10.1016/j.eururo.2023.09.003
https://pure.qub.ac.uk/en/publications/15b7c84d-5b86-46c8-b0b6-c8c3751a9fd7
https://hdl.handle.net/11585/958165
https://doi.org/10.1016/j.eururo.2023.09.003
https://www.sciencedirect.com/science/article/pii/S0302283823030920
https://www.zora.uzh.ch/id/eprint/252874/
https://doi.org/10.5167/uzh-252874

The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer

Autoren: Mamlins, Eduards Scharbert, Lara Cardinale, Jens et al.

Quelle: Mol Imaging Biol
Mamlins, Eduards; Scharbert, Lara; Cardinale, Jens; Krotov, Maria; Winter, Erik; Rathke, Hendrik; Strodel, Birgit; Ankrah, Alfred O; Sathekge, Mike; Haberkorn, Uwe; Kratochwil, Clemens; Giesel, Frederik L (2024). The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular imaging and biology, 26(1), pp. 81-89. Springer-Verlag 10.1007/s11307-023-01881-y <http://dx.doi.org/10.1007/s11307-023-01881-y>
Molecular imaging & biology 26(1), 81-89 (2024). doi:10.1007/s11307-023-01881-y

Schlagwörter: Male, SDG-03: Good health and well-being, Prostate cancer, PSMA-GCK01, Technetium-99 m, Prostatic Neoplasms, 610 Medicine & health, Prostate-specific membrane antigen (PSMA), Theranostics, Ligands, 3. Good health, Molecular Docking Simulation, 03 medical and health sciences, Single-photon emission computed tomography (SPECT), 0302 clinical medicine, Humans, Tissue Distribution, Precision Medicine, Radiopharmaceuticals, Molecular Docking Simulation [MeSH], Edetic Acid/analogs, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Radiopharmaceuticals [MeSH], Retrospective Studies [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Ligands [MeSH], Male [MeSH], Tissue Distribution [MeSH], SPECT, Prostatic Neoplasms/therapy [MeSH], Precision Medicine [MeSH], Theranostic, Research Article, Edetic Acid, Retrospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38066252
https://boris.unibe.ch/190089/
https://juser.fz-juelich.de/record/1028499
https://repository.publisso.de/resource/frl:6508695

Key considerations for a prostate cancer mRNA vaccine

Autoren: Lin, Guanjie Elkashif, Ahmed Saha, Chayanika et al.

Quelle: Lin, G, Elkashif, A, Saha, C, Coulter, J A, Dunne, N J & McCarthy, H O 2025, 'Key considerations for a prostate cancer mRNA vaccine', Critical Reviews in Oncology/Hematology, vol. 208, 104643. https://doi.org/10.1016/j.critrevonc.2025.104643

Schlagwörter: Humans, Male, Cancer Vaccines/therapeutic use, Prostatic Neoplasms/therapy, Antigens, Neoplasm/immunology, mRNA Vaccines, RNA, Messenger/genetics, Immunotherapy/methods, /dk/atira/pure/subjectarea/asjc/2700/2720, name=Hematology, /dk/atira/pure/subjectarea/asjc/2700/2730, name=Oncology, /dk/atira/pure/subjectarea/asjc/2700/2717, name=Geriatrics and Gerontology, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

Dateibeschreibung: application/pdf

Verfügbarkeit: https://pure.qub.ac.uk/en/publications/143a676d-76c3-483c-8eca-eff4c4fc5576
https://doi.org/10.1016/j.critrevonc.2025.104643
https://pureadmin.qub.ac.uk/ws/files/630151700/Key_considerations_for_a_prostate_cancer_mRNA_vaccine.pdf

Gender bias in shared decision‐making among cancer care guidelines: A systematic review: A systematic review

Autoren: Mario Rivera‐Izquierdo Marta Maes‐Carballo José J. Jiménez‐Moleón et al.

Quelle: Health Expect
Digibug. Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Health Expectations, Vol 26, Iss 3, Pp 1019-1038 (2023)

Schlagwörter: sex differences, Male, Medicine (General), Consensus, shared decision-making, Decision Making, Sexism, Prostatic Neoplasms, consensus statement, Shared, cancer treatment, 3. Good health, Endometrial Neoplasms, shared decision‐making, R5-920, 5. Gender equality, clinical guidelines, Prostatic Neoplasms/therapy, cancer diagnosis, Humans, Public aspects of medicine, RA1-1270, Endometrial Neoplasms/therapy, Review Articles, Decision Making, Shared

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37016907
https://doaj.org/article/9d1dd761e2044639942e694ae55dbb10
https://hdl.handle.net/10481/97592

Metastatic Sites’ Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review

Autoren: Mattana F. Muraglia L. Rajwa P. et al.

Weitere Verfasser: Mattana F. Muraglia L. Rajwa P. et al.

Quelle: European urology oncology, vol. 6, no. 2, pp. 128-136

Schlagwörter: Male, Positron emission tomography, Biochemical recurrence, Metastatic prostate cancer, Prostate-specific membrane antigen, Prostate-specific membrane antigen prostate cancer, Prostate, Prostatic Neoplasms, Humans, Prostate/pathology, Positron Emission Tomography Computed Tomography/methods, Neoplasm Recurrence, Local/diagnostic imaging, Neoplasm Recurrence, Local/pathology, Prostatic Neoplasms/diagnostic imaging, Prostatic Neoplasms/therapy, Prostatic Neoplasms/pathology, Positron-Emission Tomography, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Neoplasm Recurrence, Local

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36804735
https://hdl.handle.net/2434/1106388
https://doi.org/10.1016/j.euo.2023.01.014
https://serval.unil.ch/notice/serval:BIB_31C7EBBA2C16
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_31C7EBBA2C162
https://serval.unil.ch/resource/serval:BIB_31C7EBBA2C16.P001/REF.pdf
https://discovery-pp.ucl.ac.uk/id/eprint/10173098/
https://hdl.handle.net/2318/1950332
https://doi.org/10.1016/j.euo.2023.01.014

Population-based study of long-term functional outcomes after prostate cancer treatment

Autoren: Carlsson, Sigrid Drevin, Linda Loeb, Stacy et al.

Quelle: BJU International. 117(6B):E36-E45

Schlagwörter: prostate cancer, erectile dysfunction, urinary incontinence, prostatic neoplasms/therapy, quality of life

Dateibeschreibung: print

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-299050
https://doi.org/10.1111/bju.13179

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium

Autoren: Israel, JS Marcelin, L Thomas, C et al.

Weitere Verfasser: Israel, JS Marcelin, L Thomas, C et al.

Quelle: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-14 (2024)
Journal of experimental & clinical cancer research, 43(1):194

Schlagwörter: AR, Androgen deprivation therapy, Meeting Report, NR3C4, Humans [MeSH], Prostatic Neoplasms/metabolism [MeSH], Receptors, Androgen/metabolism [MeSH], PSMA, Receptors, Androgen/genetics [MeSH], PCa, Prostatic Neoplasms/genetics [MeSH], Male [MeSH], Prostatic Neoplasms/therapy [MeSH], 0301 basic medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Cancers, RC254-282

Dateibeschreibung: application/pdf

Zugangs-URL: https://doaj.org/article/39e0ffdb610b4782878eda81fbb46bd2
http://hdl.handle.net/10138/584594
https://repository.publisso.de/resource/frl:6506879

Dutch prostate cancer patients' views about exercise and experience with exercise advice: a national survey: a national survey

Autoren: Joosten, Myrthe M. Depenbusch, Johanna Samuel, Tjendo et al.

Quelle: J Cancer Surviv
Joosten, M M, Depenbusch, J, Samuel, T, Aaronson, N K, Steindorf, K & Stuiver, M M 2023, 'Dutch prostate cancer patients' views about exercise and experience with exercise advice : a national survey', Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-023-01368-3

Schlagwörter: Male, Counseling, Prostate cancer, Barriers and facilitators, Prostatic Neoplasms, Patient preferences, Middle Aged, Article, 3. Good health, Exercise Therapy, Surveys and Questionnaires, Survey research, Humans, Surveys and Questionnaires [MeSH], Aged [MeSH], Humans [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/rehabilitation [MeSH], Counseling [MeSH], Exercise, Male [MeSH], Exercise/psychology [MeSH], Exercise Therapy [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatic Neoplasms/psychology [MeSH], Netherlands [MeSH], Aged, Netherlands

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36995565
https://hdl.handle.net/20.500.11884/4c96f276-2d5c-45e4-874a-894fb37a659f
https://research.hva.nl/en/publications/4c96f276-2d5c-45e4-874a-894fb37a659f
https://doi.org/10.1007/s11764-023-01368-3
https://research.vumc.nl/en/publications/8a8c02fb-1659-4199-9040-c6f59404c1ea
https://pure.amsterdamumc.nl/en/publications/19ca88b8-64f6-4d7b-83f9-1faf4dbf7355
https://doi.org/10.1007/s11764-023-01368-3
https://repository.publisso.de/resource/frl:6519163

Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design

Autoren: Eske N. Glud Martin Rasmussen Yonghui Zhang et al.

Quelle: Br J Cancer
Glud, E N, Rasmussen, M, Zhang, Y, Mandrup, O A, Salachan, P V, Borre, M, Sørensen, K D & Howard, K A 2022, 'Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design', British Journal of Cancer, vol. 127, no. 12, pp. 2186-2197. https://doi.org/10.1038/s41416-022-01994-1

Schlagwörter: Male, 03 medical and health sciences, 0302 clinical medicine, Prostatic Neoplasms/therapy, Albumins, T-Lymphocytes, Humans, Prostatic Neoplasms, Article, 3. Good health

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36243890
https://pure.au.dk/portal/en/publications/7d5d2863-ce1e-4b1b-ac09-b6ec5480368a
https://pure.au.dk/portal/en/publications/7d5d2863-ce1e-4b1b-ac09-b6ec5480368a
https://doi.org/10.1038/s41416-022-01994-1
https://pure.au.dk/ws/files/342342266/s41416-022-01994-1.pdf
http://www.scopus.com/inward/record.url?scp=85139854650&partnerID=8YFLogxK

Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery

Autoren: Gisa Mehring Christina Steinbach Randi Pose et al.

Quelle: World J Urol

Schlagwörter: Male, Glutamate Carboxypeptidase II, Prostatectomy, L-Lactate Dehydrogenase, Prostatic Neoplasms, Middle Aged, Alkaline Phosphatase, Prognosis, Carcinoembryonic Antigen, 03 medical and health sciences, 0302 clinical medicine, Phosphopyruvate Hydratase, Antigens, Surface, Neoplasm Recurrence, Local/blood [MeSH], Antigens, Surface/blood [MeSH], Aged [MeSH], Humans [MeSH], Salvage surgery, Prostatic Neoplasms/blood [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Carcinoembryonic Antigen/blood [MeSH], Alkaline Phosphatase/blood [MeSH], Biomarker, Glutamate Carboxypeptidase II/blood [MeSH], PET, Original Article, L-Lactate Dehydrogenase/blood [MeSH], Male [MeSH], Biomarkers, Tumor/blood [MeSH], Phosphopyruvate Hydratase/blood [MeSH], Neoplasm Recurrence, Local/diagnostic imaging [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatic Neoplasms/surgery [MeSH], Biochemical recurrence, Prostatectomy/methods [MeSH], Biomarkers, Tumor, Humans, Neoplasm Recurrence, Local, Aged, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38656636
https://repository.publisso.de/resource/frl:6520329

Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre

Autoren: Herrmann, Ken Giovanella, Luca Santos, Andrea et al.

Weitere Verfasser: Herrmann, Ken Giovanella, Luca Santos, Andrea et al.

Quelle: Eur J Nucl Med Mol Imaging

Schlagwörter: Male, theranostics, Radiology, Nuclear Medicine and Imaging, Medizin, Guidelines, Sciences de la santé humaine, Iodine Radioisotopes, radionuclide theranostics, 03 medical and health sciences, 0302 clinical medicine, Prostatic Neoplasms/therapy, Medicine and Health Sciences, PSMA, Humans, nuclear medicine, Thyroid Neoplasms, Human health sciences, Precision Medicine, Radionuclide Imaging, Radiologie, médecine & imagerie nucléaire, Prostatic Neoplasms, General Medicine, Theranostics, 3. Good health, Nuclear medicine, PRRT, Radionuclide theranostics, Nuclear Medicine, Radiology, nuclear medicine & imaging

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35403861
https://pubmed.ncbi.nlm.nih.gov/35450957
https://hdl.handle.net/2268/305873
https://doi.org/10.2967/jnumed.122.264321
https://www.ncbi.nlm.nih.gov/pubmed/35403861
https://doi.org/10.1007/s00259-022-05785-x
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85128096479

The Development of iManage-PC, an Online Symptom Monitoring and Self-management Tool for Men With Clinically Localized Prostate Cancer

Autoren: Murphy, Karly M Sauer, Christina Yang, Dershung et al.

Quelle: Murphy, K M, Sauer, C, Yang, D, Hass, N, Novakovic, K, Helfand, B, Nadler, R, Schalet, B D & Victorson, D 2021, 'The Development of iManage-PC, an Online Symptom Monitoring and Self-management Tool for Men With Clinically Localized Prostate Cancer', Cancer Nursing, vol. 45, no. 1, pp. E309-E319. https://doi.org/10.1097/NCC.0000000000000948

Schlagwörter: Male, 03 medical and health sciences, 0302 clinical medicine, Prostatic Neoplasms/therapy, Self-Management, Quality of Life, Humans, Prostatic Neoplasms, Pilot Projects, Patient Reported Outcome Measures, 3. Good health

Zugangs-URL: https://journals.lww.com/cancernursingonline/Fulltext/2022/01000/The_Development_of_iManage_PC
_an_Online_Symptom.42.aspx
https://pubmed.ncbi.nlm.nih.gov/33867430
https://europepmc.org/article/MED/33867430
https://pubmed.ncbi.nlm.nih.gov/33867430/
https://research.vumc.nl/en/publications/d17bd746-73f7-42b5-bcaa-8a66148cf4ef

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients

Autoren: Andreas Becker M. Gallucci Carlo Terrone et al.

Quelle: Int Urol Nephrol

Schlagwörter: Male, Pulmonary and Respiratory Medicine, Cumulative incidence, Mortality Rates, Hazard ratio, Urology, Population, External beam radiotherapy, Proportional hazards model, Risk Assessment, Cancer-specific survival, High-risk prostate cancer, Hispanic–Latino race/ethnicity, Radical prostatectomy, Aged, Hispanic or Latino, Humans, Middle Aged, Prostatectomy, Prostatic Neoplasms, Retrospective Studies, 03 medical and health sciences, Advancements in Prostate Cancer Research, 0302 clinical medicine, Hispanic or Latino [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Male [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatectomy [MeSH], Urology - Original Paper, Global Cancer Incidence and Mortality Patterns, Propensity score matching, Health Sciences, Internal medicine, Cancer, ddc:610, Prostate cancer, Prostate Cancer, Incidence (geometry), Physics, Confidence interval, Cohort, Prostate Cancer Research and Treatment, Optics, 3. Good health, Radiation therapy, cancer-specific survival, external beam radiotherapy, high-risk prostate cancer, hispanic–latino race/ethnicity, radical prostatectomy, Environmental health, Oncology, Gynecology, Survival Rates, Medicine

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s11255-021-03055-7.pdf
https://pubmed.ncbi.nlm.nih.gov/34783982
https://pubmed.ncbi.nlm.nih.gov/34783982/
https://moh-it.pure.elsevier.com/en/publications/cancer-specific-mortality-after-radical-prostatectomy-vs-external
https://www.ncbi.nlm.nih.gov/pubmed/34783982
https://paperity.org/p/275742213/cancer-specific-mortality-after-radical-prostatectomy-vs-external-beam-radiotherapy-in
https://hdl.handle.net/11573/1639439
https://doi.org/10.1007/s11255-021-03055-7
https://repository.publisso.de/resource/frl:6445896

Time pressure predicts decisional regret in men with localized prostate cancer: data from a longitudinal multicenter study

Autoren: Caren Hilger Martin Schostak Isabella Otto et al.

Quelle: World J Urol

Schlagwörter: Male, Time pressure, Time Factors, Urologists, Decision Making, Emotions, Satisfaction with sexual life, Watchful Waiting [MeSH], Urologists [MeSH], Erectile functioning, Localized prostate cancer, Aged [MeSH], Decisional regret, Erectile Dysfunction/physiopathology [MeSH], Humans [MeSH], Sexual Health [MeSH], Longitudinal Studies [MeSH], Logistic Models [MeSH], Middle Aged [MeSH], Patient Satisfaction [MeSH], Time Factors [MeSH], Original Article, Male [MeSH], Patient Education as Topic [MeSH], Prostatic Neoplasms/therapy [MeSH], Carcinoma/therapy [MeSH], Emotions [MeSH], Decision Making [MeSH], 03 medical and health sciences, 0302 clinical medicine, Erectile Dysfunction, Patient Education as Topic, Humans, Longitudinal Studies, Watchful Waiting, 10. No inequality, Aged, Carcinoma, Prostatic Neoplasms, Middle Aged, 3. Good health, Logistic Models, Patient Satisfaction, Sexual Health, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03727-0.pdf
https://pubmed.ncbi.nlm.nih.gov/34021406
https://pubmed.ncbi.nlm.nih.gov/34021406/
https://europepmc.org/article/PMC/PMC8519821
https://link.springer.com/content/pdf/10.1007/s00345-021-03727-0.pdf
https://link.springer.com/article/10.1007/s00345-021-03727-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519821
https://repository.publisso.de/resource/frl:6447719
https://refubium.fu-berlin.de/handle/fub188/40563
https://doi.org/10.1007/s00345-021-03727-0
https://doi.org/10.17169/refubium-40283

Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance

Autoren: Valentin H. Meissner Mira Woll Donna P. Ankerst et al.

Quelle: World J Urol

Schlagwörter: Male, Prostatectomy, 2. Zero hunger, ddc:610, Clinical Decision-Making [MeSH], Watchful Waiting [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prostatic Neoplasms/mortality [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Active surveillance, Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Radical prostatectomy, Original Article, Chemotherapy, Adjuvant [MeSH], Proportional Hazards Models [MeSH], Male [MeSH], Disease-Free Survival [MeSH], Prostatic Neoplasms/therapy [MeSH], Antineoplastic Agents, Hormonal/therapeutic use [MeSH], Favorable intermediate risk, Prostatectomy [MeSH], Radiotherapy, Adjuvant [MeSH], Oncological outcome, Prostate cancer, Antineoplastic Agents, Hormonal, Clinical Decision-Making, Prostatic Neoplasms, Kaplan-Meier Estimate, Middle Aged, Risk Assessment, Disease-Free Survival, ddc, 3. Good health, Chemotherapy, Adjuvant, Humans, Radiotherapy, Adjuvant, Watchful Waiting, Aged, Proportional Hazards Models

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03717-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33973043
https://link.springer.com/content/pdf/10.1007/s00345-021-03717-2.pdf
https://link.springer.com/article/10.1007/s00345-021-03717-2
https://www.ncbi.nlm.nih.gov/pubmed/33973043
https://europepmc.org/article/MED/33973043
https://pubmed.ncbi.nlm.nih.gov/33973043/
http://www.ncbi.nlm.nih.gov/pubmed/33973043
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-920802
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/92080
https://doi.org/10.1007/s00345-021-03717-2
https://opus.bibliothek.uni-augsburg.de/opus4/files/92080/Meissner2021_Long-termAndPathologicalOutcom.pdf
https://repository.publisso.de/resource/frl:6447733
https://mediatum.ub.tum.de/doc/1638242/document.pdf